Tag: Zacks
Can Cara Therapeutics buck the trend?
Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic...
We also publish independent equity research reports, articles and interview videos on micro cap and small cap companies based on our initial research and investors interest.
We encourage OTC or NASDAQ based PUBCOS to reach out for a free coverage report.
Join our mailing list for latest coverage reports and articles, and our special coverage videos of daily market analysis on small cap companies - "Lastday Movers"
We are looking for talented interns to learn and help investors find valuable companies.
